BAOTRAN TRAN: Open Payments
NPI 1629473541 · PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 55 payments from 12 companies in 2025. Trend: 2023 $341 · 2024 $993 · 2025 $1,547
Food & beverage: $1,348Education: $199
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $466 |
| AstraZeneca Pharmaceuticals LP | 9 | $358 |
| GlaxoSmithKline, LLC. | 15 | $198 |
| GENZYME CORPORATION | 5 | $123 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| CSL Behring | 3 | $69 |
| Grifols USA, LLC | 2 | $42 |
| Optinose US, Inc. | 2 | $39 |
| Pharming Healthcare, Inc. | 1 | $28 |
Products named: DUPIXENT, FASENRA, NUCALA, Hizentra, Rhapsido, Xembify, AIRSUPRA, Xhance.
Industry payments across FL — which companies pay providers there.
